Consulting in the healthcare and pharmaceutical industry

Ian Bradley has been consulting in the healthcare industry for over 20 years, in his role as an independent and prior to that with three major consulting firms: Ian was head of the UK Healthcare practice at Arthur D Little; a Principal with Cambridge (the pricing & market access practice of IMS Health, now known as IQVIA); and a Principal Consultant at PA Consulting Group. Ian has a track record of shaping and leading major pieces of strategic analysis and change in the pharmaceutical and healthcare industries, including:

• Product strategy and launch, especially global pricing and market access for new medicines; Ian has been involved in the launch or R&D progression of many new pharmaceutical brands, the vast majority of them developed by pharmaceutical companies in the ‘top ten’

• Distribution and operational strategy in pharmaceuticals, including supply integrity and cross-border trade programmes

• R&D strategy, therapy area strategy and business alliances in the healthcare industry, including long-term R&D strategy for a major European-based healthcare and life sciences busines

• Partnering strategy and intellectual property management for major global pharmaceutical manufacturers

• Work for public policy makers in the field of healthcare and health R&D, including recent work on drug pricing policy and on R&D funding for clinical research